University of Pittsburgh Law Review is a prestigious academic journal that stands as a cornerstone in the field of legal scholarship. Published by the University of Pittsburgh, University Library System, this journal has been contributing to the discourse of the law since its inception, exemplifying a commitment to advancing scholarly work in various legal domains. Although its open access options are limited, the robust collection of articles and commentaries—spanning from 1973 to the present—provides an invaluable resource for researchers, professionals, and students alike. The journal currently ranks in the Q4 quartile within the field of law for 2023, indicating a specialized focus and offering significant opportunities for legal analysis and research. Positioned in a competitive landscape as Rank #784 out of 1025 in Scopus for Social Sciences - Law, it is an essential platform for emerging voices and innovative ideas that shape legal thought and policy. The University of Pittsburgh Law Review continues to foster critical examination and discussion, making it a vital resource for anyone engaged in the study or practice of law.

Medecine & Droit, an esteemed journal published by ELSEVIER MASSON, CORP OFF, serves as a vital resource for the intersection of law and medicine. Since its inception in 1995, this journal has facilitated scholarly discourse by publishing innovative research, case studies, and reviews that explore the complexities of legal frameworks impacting medical practice and public health. Although currently classified in the fourth quartile within both the Law and Medicine (miscellaneous) categories for 2023, its contributions are important for legal professionals and healthcare providers seeking to navigate the evolving landscape of medical laws. With an ISSN of 1246-7391 and E-ISSN 1873-6475, it provides essential insights and stimulates interdisciplinary collaboration within academia. Authors and researchers are encouraged to contribute and engage with critical topics shaping the future of medicine and law through this essential publication.

BioLaw Journal-Rivista di Biodiritto, published by UNIV TRENTO, FAC LAW, stands as a vital interdisciplinary platform in the domains of biolaw, biotechnology, and health policy. With an ISSN of 2284-4503 and a burgeoning reputation, this journal encourages critical discussions surrounding the ethical, legal, and social implications of biotechnological advancements from 2014 to 2024. Ranked Q3 in both Biochemistry and Biotechnology, alongside Q2 rankings in Law and Philosophy, it reflects a growing body of scholarship in these experimental fields. Although currently categorized with varying percentile ranks in the Scopus database, it underlines the journal's commitment to nurturing innovative research and interdisciplinary dialogue. The journal promotes open access principles, although the specific access options should be verified for each article. It serves as an indispensable resource for researchers, professionals, and students engaged in the evolving intersection of law and biotechnology, making it a key player in shaping future discourses in bioethics and policy.

AMERICAN JOURNAL OF LAW & MEDICINE is a prestigious interdisciplinary journal published by Cambridge University Press that bridges the critical intersection of legal and medical scholarship. Since its inception in 1975, this journal has fostered scholarly dialogue surrounding complex legal issues affecting health care and medical ethics, significantly contributing to the fields of law and the social sciences. With its current impact factor highlights showcasing a Q2 ranking in Law and Q3 in Health (Social Science), along with a solid readership base, the journal appeals to researchers, legal professionals, and students alike, offering a platform for impactful research and case studies. Although it does not currently provide Open Access options, the journal continues to prioritize rigorous peer-reviewed content, ensuring that essential discussions on law and medicine remain accessible to its readership. By engaging with contemporary legal and medical issues, the AMERICAN JOURNAL OF LAW & MEDICINE plays a vital role in advancing knowledge and shaping practices within these dynamic fields.

Health Economics Policy and Law is a premier journal published by Cambridge University Press that focuses on the intersection of health economics, policy formulation, and legal frameworks. Since its establishment in 2006, the journal has been at the forefront of disseminating high-quality research, covering critical issues in the ever-evolving health policy landscape. With an impressive impact factor and ranked in the Q1 category of Health Policy according to the latest metrics (2023), it serves as a vital resource for academic researchers, professionals, and students alike. The journal aims to stimulate discussion and influence decision-making by providing rigorous empirical studies, policy analyses, and theoretical evaluations. While not open access, its publications are accessible through institutional subscriptions, reflecting its commitment to supporting scholarly discourse within the field. As it continues to converge towards its 2024 goals, Health Economics Policy and Law remains an essential platform for advancing knowledge and fostering innovation in health policy and law.

JMA Journal, established by the Japan Medical Association in collaboration with the Japanese Association of Medical Sciences, serves as a pivotal platform for disseminating cutting-edge research and advancements in the field of medicine. With its ISSN number 2433-328X and E-ISSN 2433-3298, the journal aims to foster scientific dialogue among researchers, clinicians, and medical scholars in Japan and globally. Although currently not an Open Access journal, the JMA Journal emphasizes quality and rigor in its peer-reviewed publications, striving to contribute substantial insights to the medical community. With a growing impact in the field and a commitment to promoting evidence-based practices, the journal is vital for professionals and students seeking to stay abreast of the latest developments in medical science.

The Journal of Bioethical Inquiry, published by Springer, is a prominent academic journal in the fields of bioethics, health policy, and social sciences. Established in 2004 and running through 2024, it is recognized for providing a critical platform for the exploration of ethical issues arising in the contexts of healthcare and policy making. With an ISSN of 1176-7529 and an E-ISSN of 1872-4353, this esteemed journal holds a Q2 quartile ranking in both Health Policy and Health (Social Science) categories, indicating its significant impact and contributions to the field. It boasts impressive Scopus rankings, with a standing of #70 out of 371 in Social Sciences _ Health (Social Science) and #68 out of 310 in Medicine _ Health Policy, representing its relevance and authority in these domains. Although it does not currently offer open access options, the Journal of Bioethical Inquiry remains a vital resource for researchers, practitioners, and students eager to engage with the complexities of bioethical challenges and to advance the discourse on health policies.

Welcome to the McGill Journal of Law and Health, a distinguished publication that uniquely intersects the fields of law and health policy, published by McGill University, Faculty of Law. Operating from the vibrant city of Montreal, Canada, this journal serves as a vital forum for scholars, practitioners, and students who are passionate about exploring the intricate relationship between legal frameworks and health systems. With an ISSN of 1920-4825, the journal encapsulates a rigorous approach to examining pressing legal issues affecting public health and is committed to advancing knowledge and discussion within its scope. Ranked within the Q3 category in Law and Q4 in Health Policy for 2023, it is positioned to facilitate significant contributions to both academic and practical landscapes. It features an array of research articles, case studies, and policy analyses that are freely accessible, fostering an inclusive environment for knowledge-sharing. The McGill Journal of Law and Health is an essential resource for those aiming to engage with contemporary debates and findings at the intersection of law and health, offering insights that are crucial for informed decision-making and advocacy in this evolving field.

Revista de Direito Sanitario-Journal of Health Law is a prominent academic publication in the field of health law, published by the esteemed University of São Paulo (UNIV SAO PAULO), Brazil. With a focus on the intersection of law and public health, this Open Access journal has been disseminating vital research since its inception in 2013, allowing for wide accessibility and engagement from scholars and practitioners alike. The journal serves as a critical forum for advancing discussions on health-related legal issues, policy implications, and regulatory frameworks. While currently positioned in the fourth quartile in health (social science) and medicine (miscellaneous), and the third quartile in law, its acceptance and visibility continue to grow within the global academic community. The insights shared in this journal are invaluable for those striving to enhance legal practice and health policy, making it an indispensable resource for researchers, professionals, and students committed to the advancement of health law and its implications in society.

Ethik in der Medizin, published by Springer, is a distinguished journal focusing on the interdisciplinary aspects of ethics in medicine, healthcare policy, and philosophical inquiries related to these domains. With an ISSN of 0935-7335 and an E-ISSN of 1437-1618, this journal serves as a platform for innovative research and discussion from Germany and beyond. The journal boasts an impact in several prestigious categories including Q3 in Health Policy and Q2 in Philosophy as of 2023, reflecting its significant contribution to the discourse on ethical implications in health and medicine. Although not currently Open Access, Ethik in der Medizin provides valuable insights for researchers, professionals, and students interested in the complexities of health ethics and policies, positioning itself as an essential resource in academia. The journal is undergoing important developments, as it converges from 2001 with a publishing timeline extending to 2024, ensuring continued relevance in a rapidly evolving field.